Fate Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
57.10
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
6
|
|
# Buys
|
2
|
|
# Holds
|
14
|
|
# Sells
|
2
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.89
|
-0.86
|
0.03
|
3.37%
|
|
2022-06-30
|
-0.83
|
-0.79
|
0.04
|
4.82%
|
|
2022-03-31
|
-0.76
|
-0.68
|
0.08
|
10.53%
|
|
2021-12-31
|
-0.67
|
-0.72
|
-0.05
|
-7.46%
|
|
2021-09-30
|
-0.58
|
-0.45
|
0.13
|
22.41%
|
|
2021-06-30
|
-0.53
|
-0.58
|
-0.05
|
-9.43%
|
|
2021-03-31
|
-0.43
|
-0.48
|
-0.05
|
-11.63%
|
|
2020-12-31
|
-0.39
|
-0.61
|
-0.22
|
-56.41%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.33
|
|
2021-12-31
|
-2.23
|
|
2020-12-31
|
-2.08
|
|
2019-12-31
|
-1.43
|
|
2018-12-31
|
-1.20
|
|
2017-12-31
|
-1.02
|
|
2016-12-31
|
-1.06
|
|
2015-12-31
|
-1.21
|
|
2014-12-31
|
-1.26
|
|
2013-12-31
|
-5.10
|